SE0200876L - Nässpray mot öroninflammationer - Google Patents

Nässpray mot öroninflammationer

Info

Publication number
SE0200876L
SE0200876L SE0200876A SE0200876A SE0200876L SE 0200876 L SE0200876 L SE 0200876L SE 0200876 A SE0200876 A SE 0200876A SE 0200876 A SE0200876 A SE 0200876A SE 0200876 L SE0200876 L SE 0200876L
Authority
SE
Sweden
Prior art keywords
nasal spray
ear inflammation
spray against
against ear
medicament
Prior art date
Application number
SE0200876A
Other languages
English (en)
Other versions
SE0200876D0 (sv
Inventor
Krister Tano
Original Assignee
Krister Tano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krister Tano filed Critical Krister Tano
Priority to SE0200876A priority Critical patent/SE0200876L/sv
Publication of SE0200876D0 publication Critical patent/SE0200876D0/sv
Priority to AU2003215987A priority patent/AU2003215987A1/en
Priority to US10/508,590 priority patent/US20050238635A1/en
Priority to AT03745048T priority patent/ATE347370T1/de
Priority to EP03745048A priority patent/EP1490096B1/en
Priority to PCT/SE2003/000384 priority patent/WO2003080109A1/en
Priority to DE60310212T priority patent/DE60310212T2/de
Priority to ES03745048T priority patent/ES2277641T3/es
Publication of SE0200876L publication Critical patent/SE0200876L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01001—NADH peroxidase (1.11.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
SE0200876A 2002-03-22 2002-03-22 Nässpray mot öroninflammationer SE0200876L (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer
AU2003215987A AU2003215987A1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
US10/508,590 US20050238635A1 (en) 2002-03-22 2003-03-06 Use of hyrogen peroxide producting enzyme for treatment of otitis media
AT03745048T ATE347370T1 (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid produzierenden enzyms zur behandlung von otitis media
EP03745048A EP1490096B1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
PCT/SE2003/000384 WO2003080109A1 (en) 2002-03-22 2003-03-06 Use of hydrogen peroxide producing enzyme for treatment of otitis media
DE60310212T DE60310212T2 (de) 2002-03-22 2003-03-06 Verwendung eines wasserstoffperoxid-produzierenden Enzyms zur Behandlung von Otitis Media
ES03745048T ES2277641T3 (es) 2002-03-22 2003-03-06 Utilizacion de una enzima productora de peroxido de hidrogeno para el tratamiento de otitis media.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Publications (2)

Publication Number Publication Date
SE0200876D0 SE0200876D0 (sv) 2002-03-22
SE0200876L true SE0200876L (sv) 2003-09-23

Family

ID=20287356

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200876A SE0200876L (sv) 2002-03-22 2002-03-22 Nässpray mot öroninflammationer

Country Status (8)

Country Link
US (1) US20050238635A1 (sv)
EP (1) EP1490096B1 (sv)
AT (1) ATE347370T1 (sv)
AU (1) AU2003215987A1 (sv)
DE (1) DE60310212T2 (sv)
ES (1) ES2277641T3 (sv)
SE (1) SE0200876L (sv)
WO (1) WO2003080109A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
EP2276505B1 (en) * 2008-03-20 2013-09-18 TANO, Krister Nasal spray or nasal drops for treatment of common cold
EP3245871A1 (en) 2014-04-30 2017-11-22 Matoke Holdings Limited Antimicrobial compositions
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702831L (sv) * 1987-07-10 1989-01-11 Ewos Ab Microbicid komposition
GB9002422D0 (en) * 1990-02-03 1990-04-04 Boots Co Plc Anti-microbial compositions
KR930703012A (ko) * 1991-02-21 1993-11-29 잭슨 티. 스티븐스 쥬니어 폴로라의 조절 및 감염의 치료를 위한 방법 및 이것의 조성물
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
SE506529C2 (sv) * 1996-01-23 1997-12-22 Semper Ab Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9708641D0 (en) * 1997-04-29 1997-06-18 Knoll Ag Enzyme concentrate
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner Nasenspray-Flüssigkeit
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats

Also Published As

Publication number Publication date
EP1490096A1 (en) 2004-12-29
DE60310212T2 (de) 2007-10-11
EP1490096B1 (en) 2006-12-06
DE60310212D1 (de) 2007-01-18
US20050238635A1 (en) 2005-10-27
WO2003080109A1 (en) 2003-10-02
SE0200876D0 (sv) 2002-03-22
ES2277641T3 (es) 2007-07-16
AU2003215987A1 (en) 2003-10-08
ATE347370T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
AU2003239557A1 (en) Catheter balloon with ultrasonic microscalpel blades
MY144292A (en) Method of reducing oral tissue inflammation using magnolia extract
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
HUP0400689A2 (hu) ABCA-1 szint-emelő vegyületek
EP1466912A4 (en) 2-ACYLAMINOTHIAZOLE DERIVATIVE AND SALT THEREOF
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
SE9702860D0 (sv) New use
WO2005094836A3 (en) Use of loteprednol etabonate for the treatment of dry eye
GB2432314B (en) Topical medicament comprising menthol, camphor, potassium and a source of oxygen
EP2099466A4 (en) USE OF HYDROLYTIC AND OXIDATIVE ENZYMES FOR RESOLVING BIOFIMES IN EARS
AU2001236886A1 (en) Use of relaxin to treat diseases related to vasoconstriction
PL362803A1 (en) Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
AU2002234806A1 (en) Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
WO2001089536A3 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
NZ507203A (en) Use of dexmedetomidine for ICU sedation
SE0200876L (sv) Nässpray mot öroninflammationer
AU2002332488A1 (en) R-bambuterol, its preparation and therapeutic uses
AR040657A1 (es) Tirita para refrescar el aliento mejorada por enzimas
WO2006101954A3 (en) Interstitial cystitis treatment
WO2004060236A3 (en) Thin curved elasticized absorbent article with absorbent concentration profile
EP1495755B8 (fr) Utilisation de la citrulline dans la fabrication d'un médicament pour le traitement de l'insuffisance intestinale liée au vieillissement ou à une irradiation
MXPA05005911A (es) Utilizacion del acido docosahexaenoico como sustancia activa para el tratamiento de la lipodistrofia.
WO2002051404A8 (fr) Compositions orales

Legal Events

Date Code Title Description
NAV Patent application has lapsed